Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis
Authors:
- 28 February 2024
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 368, 219-232
Abstract
No abstract availableKeywords
Funding Information
- Liaoning Province Educational Department
- Department of Science and Technology of Liaoning Province
- Shenyang Pharmaceutical University Shenyang Key Laboratory of Functional Drug Carrier Materials
This publication has 46 references indexed in Scilit:
- Remodeling Collagen Microenvironment in Liver Using a Biomimetic Nano‐Regulator for Reversal of Liver FibrosisAdvanced Science, 2023
- Peptide‐Based Nanoarchitectonics for the Treatment of Liver FibrosisChemBioChem, 2023
- Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapyActa Biomaterialia, 2022
- Liver fibrosis: Extracellular vesicles mediated intercellular communication in perisinusoidal spaceHepatology, 2021
- Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate CellsAdvanced Science, 2021
- Nitric Oxide‐Driven Nanomotor for Deep Tissue Penetration and Multidrug Resistance Reversal in Cancer TherapyAdvanced Science, 2020
- Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular RegulationAdvanced Science, 2020
- Retinoic Acid Receptor‐β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin‐Driven Activation and Durotaxis in Hepatic Stellate CellsHepatology, 2018
- The Use of Nanoparticles to Deliver Nitric Oxide to Hepatic Stellate Cells for Treating Liver Fibrosis and Portal HypertensionSmall, 2015
- Liver sinusoidal endothelial cells in hepatic fibrosisHepatology, 2014